entity

synaptic protection

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about synaptic protection: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
7Hypotheses
1Analyses
0Outgoing
1Incoming
9Experiments
2Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
GFAPmodulatesprotein0.70

Targeting Hypotheses (7)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Complement Cascade Inhibition Synaptic Protection 0.867 neurodegeneration View
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio 0.844 neurodegeneration Lipid raft composition changes in synapt
Complement-Mediated Synaptic Protection 0.580 neurodegeneration Neuroinflammation and microglial priming
Synaptic protection via microglial/complement normalization 0.560 neurodegeneration Does the cancer-cystatin-C-TREM2 pathway
NFκB/C1Q SASP Modulation for Synaptic Protection 0.534 neurodegeneration View
CYP2J2-Generated DHA Epoxides Enhance LXRβ-Mediated APOE Lip 0.380 lipidomics Lipid metabolism dysregulation in Alzhei
IL-33/ST2 Axis Augmentation for Synaptic Protection 0.105 neurodegeneration Neuroinflammation Biomarker Panel for Ea

Mentioning Analyses (1)

Scientific analyses that reference this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

neurodegeneration | 2026-04-10 | 0 hypotheses

Experiments (9)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
C1q neutralization experiment validation perioperative neurocognitive d 0.900 0.00 rats proposed N/A
scRNA-seq analysis of human atherosclerotic plaques exploratory Atherosclerosis 0.900 0.00 human atherosclerotic plaque s proposed N/A
Sevoflurane-induced neurotoxicity (SIN) model in rats validation perioperative neurocognitive d 0.900 0.00 rats proposed N/A
Machine learning-based identification of C1Q hub genes exploratory Atherosclerosis 0.900 0.00 Human bulk RNA sequencing data proposed N/A
Gene expression validation in apoE-/- mice validation Atherosclerosis 0.850 0.00 apoE-/- mice proposed N/A
ox-LDL treatment of RAW264.7 macrophages exploratory Atherosclerosis 0.850 0.00 RAW264.7 macrophages proposed N/A
nSMase2 Inhibitor DPTIP Rescues Synaptic Density in APPswe/PS1deltaE9 in_vivo Alzheimer's disease 0.803 0.74 APPswe/PS1dE9 bigenic mice, 6- proposed $62,000
Validation of hub genes in ox-LDL treated RAW264.7 macrophages exploratory Atherosclerosis 0.800 0.00 RAW264.7 macrophages proposed N/A
Validation of hub genes in apoE-/- atherosclerotic mice validation Atherosclerosis 0.800 0.00 apoE-/- mice proposed N/A

Related Papers (15)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Sustained inhibitory dysfunction in complement component C1qa-deficient mice und [PMID:41544964] Righes Marafiga J, Vu T, Bowlus J, Barab Progress in neurobiology 2026 0
Synaptic pruning genes networks in Alzheimer's disease: correlations with neurop [PMID:40515808] Sanfilippo C, Castrogiovanni P, Imbesi R Geroscience 2026 0
Robust characterization and interpretation of rare pathogenic cell populations f [PMID:41547856] Zhang X, Yu Z, Hao G, Yao Q, Hu Y et al. Nat Commun 2026 0
Structural signature of plasma proteins classifies the status of Alzheimer's dis [PMID:41760935] Son A, Kim H, Diedrich JK, Bamberger C, Nat Aging 2026 0
Synaptic pruning genes networks in Alzheimer's disease: correlations with neurop [PMID:40515808] Sanfilippo C, Castrogiovanni P, Imbesi R GeroScience 2026 0
Phosphoproteomics uncovers a neuroimmune perspective on trigeminal neuralgia: se [PMID:41853292] Zhai X, Lin X, Zhang L, Ren Y, Miao H, M Frontiers in immunology 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Role of neuroinflammation in neurodegeneration development. [PMID:37433768] Zhang W, Xiao D, Mao Q, Xia H Signal transduction and target 2023 0
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. [PMID:36890231] Chen X, Firulyova M, Manis M, Herz J, Sm Nature 2023 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Multiple Sclerosis Pathology. [PMID:29358320] Lassmann H Cold Spring Harbor perspective 2018 0
Microglia Function in the Central Nervous System During Health and Neurodegenera [PMID:28226226] ["Colonna Marco", "Butovsky Oleg"] Annual review of immunology 2017 0
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169] ["Oakley, Holly", "Cole, Sarah L", "Loga The Journal of neuroscience : 2006 0

Debates (2)

Multi-agent debates referencing this entity

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.66 · 2026-04-21

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

closed · Rounds: 0 · Score: 0.64 · 2026-04-21

Related Research

Hypotheses and analyses mentioning synaptic protection in their description or question text

CYP2J2-Generated DHA Epoxides Enhance LXRβ-Mediated APOE Lipidation for Synergis

Score: 0.380 · lipidomics · 2026-04-26

This hypothesis proposes that CYP2J2-generated DHA epoxides act as endogenous LXRβ agonists, creating a synergistic mech

IL-33/ST2 Axis Augmentation for Synaptic Protection

Score: 0.105 · neurodegeneration · 2026-04-18

## Mechanistic Overview IL-33/ST2 Axis Augmentation for Synaptic Protection starts from the claim that modulating not ye